查询词典 follow up

Previously, Dr. Mahon and colleagues conducted a pilot study and explored the feasibility of discontinuing imatinib in CML patients who had experienced a complete molecular response. Of the 15 patients included in the cohort, 7 relapsed within 6 months, but they were able to reattain a complete molecular response after imatinib was restarted. The other 8 patients remain in remission after the discontinuation of imatinib (median follow-up is 37 months).

之前，Mahon医师等人主导一个先驱研究，探索完整分子生物学上缓解之CML病患停用imatinib的可能性，在总共15名病患中，7人在6个月内復发，但他们可以在再度使用imatinib之后再度达到完整分子生物学上缓解，其他8个病患在停用imatinib之后持续缓解(平均追踪期为37个月)。

Previously, Dr. Mahon and colleagues conducted a pilot study and explored the feasibility of discontinuing imatinib in CML patients who had experienced a complete molecular response. Of the 15 patients included in the cohort, 7 relapsed within 6 months, but they were able to reattain a complete molecular response after imatinib was restarted. The other 8 patients remain in remission after the discontinuation of imatinib (median follow-up is 37 months).

之前，Mahon医师等人主导一个先驱研究，探索完整分子生物学上缓解之CML病患停用imatinib的可能性，在总共15名病患中，7人在6个月内复发，但他们可以在再度使用imatinib之后再度达到完整分子生物学上缓解，其他8个病患在停用imatinib之后持续缓解(平均追踪期为37个月)。

Previously, Dr. Mahon and colleagues conducted a pilot study and explored the feasibility of discontinuing imatinib in CML patients who had experienced a complete molecular response. Of the 15 patients included in the cohort, 7 relapsed within 6 months, but they were able to reattain a complete molecular response after imatinib was restarted. The other 8 patients remain in remission after the discontinuation of imatinib (median follow-up is 37 months).

之前，Mahon医师等人主导一个先驱研究，探索完整分子生物学上缓解之CML病患停用imatinib的可能性，在总共15名病患中，7人在6个月内复发，但他们可以在再度使用imatinib之后再度达到完整分子生物学上缓解，其它8个病患在停用imatinib之后持续缓解(平均追踪期为37个月)。

Results:Follow up was one month to two years.25 cases were cured .1 case of recrudescent squamous cell carcinoma is recrudesced.

结果 26例患者经改良Mohs显微描记手术治疗，所有切口均Ⅰ期愈合，皮片或皮瓣均成活，随访1个月～2年，除一例头皮复发性鳞状细胞癌术后一月复发外，余患者均治愈，肿瘤无复发。

OBJECTIVE: We report a case of solitary Peutz-Jeghers-type hamartomatous polyp in the recta and more melanocytes, study the clinicopathologic features and recognize the importanc of the follow-up.

目的：报告1例发生于直肠的错构瘤性息肉(Peutz-Jeghers)合并大量黑色素细胞，以探讨此类少见病例的临床病理特征以及鉴别诊断及随访重要性。

A solitary Peutz-Jeghers-type is rare, and hamartomatous polyp in the recta and more spindle melanocytes was very rare, not only the diagnosis but also reconstruction follow-up and prognosis are important.

发生于直肠的错构瘤性息肉少见，息肉伴大量黑色素细胞聚集更为罕见，病理诊断困难，所以病理医生要重视并加强对患者的随访，以检验诊断的准确性。

RESULTS: Pathological diagnosis: hamartomatous polyp in the recta, but no besides malignant melanoma or blue nevus, suggesting to extend removal and close follow-up.

结果：病理诊断为直肠错构瘤性息肉合并大量黑色素细胞，不除外恶性黑色素瘤或蓝痣基础上恶变，建议扩大切除，密切随诊。

Methods Auto-corneal limbus stem cell transplantation combined with MitomycinC (0.02%MMC) after excision were performed in 48 patient (51eyes)with pterygium. The recurrency rate was observed over a 6-18 months follow-up period.

对48例51只眼翼状胬肉患者，行翼状胬肉切除，同时术中应用0.02%MMC联合自体角膜缘干细胞移植，术后随访胬肉复发情况。

Results 28 cases follow-up 5~12 months, the appearance of penis was normal and no recurvation.

结果 随访28例5～12月，阴茎外观正常无下弯。

"Although a longer follow-up is required for assessment of the durability of response, the patient's course indicates that autologous hematopoietic stem cell transplantation may be a way to reinduce tolerance in patients with SLE," the authors write.

作者写道：「尽管仍需要更长时间的随访，来评价这种治疗效果的持久程度，但是患者的治疗过程提示，自身同源性血液干细胞的移植，可能是患有SLE患者再次唤起免疫耐受的一种方法。

Finally, according to market conditions and market products this article paper analyzes the trends in the development of camera technology, and designs a color night vision camera.

最后根据市场情况和市面上产品的情况分析了摄像机技术的发展趋势，并设计了一款彩色夜视摄像机。

Only person height weeds and the fierce looks stone idles were there.

只有半人深的荒草和龇牙咧嘴的神像。